Elevated high sensitivity c-reactive protein in patients with subclinical hypothyroidism: A case control study
Author(s) -
Deepak Kumar Dasmohapatra,
Anuradha Panda,
Aditya Narayan Dash,
Babita Ekka
Publication year - 2022
Publication title -
panacea journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2348-7682
pISSN - 2249-8176
DOI - 10.18231/j.pjms.2022.017
Subject(s) - euthyroid , medicine , subclinical infection , c reactive protein , endocrinology , lipid profile , gastroenterology , inflammation , thyroid , cholesterol
Inflammation in subclinical Hypothyroidism (SCH) imposes a significant cardiovascular risk. The aim of the present study was to assess the elevated levels of high sensitivity C-reactive protein (hs-CRP) in SCH patients. In this study, 50 cases of SCH and 50 cases of euthyroid were selected. The complete history of the subjects were taken and demographic , biochemical parameters like age, BMI, thyroid profiles, lipid profiles and hsCRP were estimated. The mean TSH levels were significantly (p<0.05) elevated in SCH cases as that of the controls (8.56± 1.76 vs 2.28± 0.65 μU/ml). Further, hs-CRP level was significantly (p<0.05) higher in SCH cases as that of the controls (2.93 ±0.87 vs 1.16 ±0.45 mg/l). Meanwhile, lipid profiles were also elevated in SCH cases as that of the controls. Coefficient correlation analysis showed significant association between TSH and hs-CRP. Thus, increased level of hs-CRP in SCH highlights the inflammatory status and thus associated with the development of cardiovascular diseases in SCH.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom